Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205

Por Li, T., Christos, P. J., Sparano, J. A., Hershman, D. L., Hoschander, S., O'Brien, K., Wright, J. J., Vahdat, L. T.
Publicado em 2009

Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary†‡

Por Chuang, E., Wiener, N., Christos, P., Kessler, R., Cobham, M., Donovan, D., Goldberg, G. L., Caputo, T., Doyle, A., Vahdat, L., Sparano, J. A.
Publicado em 2010

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

Por Barta, S. K., Samuel, M. S., Xue, X., Wang, D., Lee, J. Y., Mounier, N., Ribera, J.-M., Spina, M., Tirelli, U., Weiss, R., Galicier, L., Boue, F., Little, R. F., Dunleavy, K., Wilson, W. H., Wyen, C., Remick, S. C., Kaplan, L. D., Ratner, L., Noy, A., Sparano, J. A.
Publicado no Ann Oncol (2015)

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Por Sparano, J.A., Gray, R.J., Makower, D.F., Pritchard, K.I., Albain, K.S., Hayes, D.F., Geyer, C.E., Dees, E.C., Perez, E.A., Olson, J.A., Zujewski, J.A., Lively, T., Badve, S.S., Saphner, T.J., Wagner, L.I., Whelan, T.J., Ellis, M.J., Paik, S., Wood, W.C., Ravdin, P., Keane, M.M., Gomez Moreno, H.L., Reddy, P.S., Goggins, T.F., Mayer, I.A., Brufsky, A.M., Toppmeyer, D.L., Kaklamani, V.G., Atkins, J.N., Berenberg, J.L., Sledge, G.W.
Publicado no N Engl J Med (2015)